A 62-year-old woman with ischemic cardiomyopathy (left ventricular ejection fraction, 15%) underwent Heart-Mate II (Thoratec, Inc, Pleasanton, CA) left ventricular assist device (LVAD) placement in January 2011 for cardiogenic shock. After implantation, the patient's hemodynamic status improved, but she had multiple episodes of ventricular tachycardia (VT) leading to implantable cardioverterdefibrillator therapies. The episodes led to marked reduction Figure 1. CT scan, voltage map, and ECG. A, Preprocedure CT imaging demonstrating the left ventricular assist device inflow cannula site as well as the site of anterolateral thoracotomy (yellow arrow). B, Electroanatomic mapping of the left ventricular (LV) epicardium revealed a moderate basal to mid-lateral LV scar, with C, best pace maps to the clinical ventricular tachycardia emanating from the basal aspect of the scar (white arrow).
. CT scan, voltage map, and ECG. A, Preprocedure CT imaging demonstrating the left ventricular assist device inflow cannula site as well as the site of anterolateral thoracotomy (yellow arrow). B, Electroanatomic mapping of the left ventricular (LV) epicardium revealed a moderate basal to mid-lateral LV scar, with C, best pace maps to the clinical ventricular tachycardia emanating from the basal aspect of the scar (white arrow).
in LVAD flows and presyncope. Amiodarone, mexilitine, and quinidine therapy did not change the VT burden. The patient underwent endocardial catheter ablation in March 2011 at an outside institution. During this procedure, the basal lateral LV was noted to have low voltage consistent with scar, yet pace maps obtained in this region did not match the clinical VT. Despite extensive ablation of late potentials and scar border zones, the clinical VT remained inducible.
In April 2011, the patient underwent epicardial mapping and ablation of VT at our institution. Because the patient had previous cardiac surgery and the 12-lead ECG of the clinical VT suggested a basal anterolateral exit, epicardial access was obtained by limited anterior thoracotomy in the cardiac catheterization laboratory, as described previously. 1 Based on the clinical VT morphology and preprocedure CT, the fourth intercostal space was chosen for the incision ( Figure 1A ).
Noninvasive programmed stimulation induced the same clinical VT with a cycle length 490 ms. This led to reduced LVAD flows with hypotension, requiring prompt termination. The clinical VT was reproducibly inducible with double ventricular extrastimuli. A substrate and pace-mapping approach was used, given the hemodynamic instability during VT. The initial sinus voltage map using the EnSite Velocity (St Jude Medical, St Paul, MN) system revealed a dense epicardial scar (Յ0.5 mV) in the mid to basal anterolateral LV ( Figure 1B) . Pacing from the basal aspect of the scar revealed a close but not perfect pace match to the clinical VT ( Figure 1C ). The patient had significant blood loss through the surgical wound and "weeping" of blood from the epicardium, eventually requiring blood transfusion during the procedure. The ongoing bleeding forced a time pressure for completion of the procedure. Based on previous experience of steam pops and the time needed to create lesions with a closed irrigated catheter, 1 we elected to use a surgical tool for cardiac ablation, the Isolator Coolrail (Atricure Inc, West Chester, OH) bipolar surgical linear ablation pen ( Figure 2B ). Before ablation with this device, mapping was performed with the Chilli (Boston Scientific, Natick, MA) catheter with the Isolator Coolrail linear pen fixated to this catheter with silk suture ties. Once a suitable position was determined, based on pace maps and electroanatomic mapping, coronary angiography was performed, documenting a sufficient distance from epicardial coronary arteries (Figure 2A ). Three lesions (40, 29, and 40 seconds) were delivered with the Isolator Coolrail ablation linear pen at 30 W of power. The second ablation lesion was stopped at 29 seconds because of a sudden impedance rise. After ablation, repeat programmed stimulation induced a different VT with a superior axis, which had not been seen clinically. The clinical VT was not induced again after ablation despite multiple inductions. The ablated region ( Figure 3 ) was completely devoid of electric signals and was electrically unexcitable (Figure 4 ). All antiarrhythmics (except amiodarone) were discontinued, and the patient was discharged 5 days after the procedure. At 3-month follow-up, the patient had no recurrent VT.
Discussion
We report a case of a hybrid surgical epicardial VT ablation in a patient with an LVAD, using a surgical ablation tool. To our knowledge, this is the first use of this ablation technology on the epicardial surface for VT. 
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The Coolrail bipolar surgical linear ablation system is composed of a distal tip that has two 30-mm electrodes. Bipolar radiofrequency energy is delivered between the 2 electrodes. Both electrodes are continuously cooled through an internal irrigation system, allowing for lower temperatures at the catheter-tissue interface, leading to lesion depth of 4 to 5 mm. 2 Further, the distal shaft and catheter tip are flexible, allowing for full-length contact with the myocardium. To date, epicardial ablation for atrial fibrillation is the most widely used application for this system.
Although the surgical ablation system led to successful ablation, it is likely that standard irrigated radiofrequency catheter ablation may also have succeeded. Because the current surgical ablation system does not allow for mapping, a mapping catheter must be used as well. In our case, the Chilli catheter was used for mapping with the surgical ablation system overlying the catheter before ablation.
The surgical tool was used to deliver energy to a broad region in a short time to minimize further bleeding in our patient. However, because of the large area of ablation with each lesion, this technology can potentially ablate normal tissue, leading to collateral damage to normal myocardium. Given that this patient was on complete LVAD support, ablation of normal myocardium was less of a concern; however, the use of this ablation technology may be limited in other patients with less myocardial reserve. Patients requiring ablation of a broad region of ventricular myocardi-um with relatively stable hemodynamics may benefit from this ablation technology.
Conclusions
We describe the use of a surgical ablation system to successfully ablate an epicardial VT, utilizing a hybrid epicardial surgical approach in a patient with an LVAD. This ablation technology may be considered in select cases of hybrid surgical epicardial VT ablation and warrants further investigation.
Sources of Funding
This work was supported by the National, Heart, Lung, and Blood Institute (RO1 HL084261). 
e86
Circ Arrhythm Electrophysiol December 2011
